Zevra Therapeutics (ZVRA) Gross Margin (2019 - 2026)
Zevra Therapeutics (ZVRA) posted Gross Margin of 95.25% for Q3 2026, unchanged from 95.26% a year earlier and down 0.90 percentage points from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Gross Margin (2019 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Gross Margin at Zevra Therapeutics was 95.44%, up 14.79 percentage points year-over-year; for FY2025, it was 84.52%, up 15.94 percentage points from FY2024.
- Annual Gross Margin shows a four-year change of -8.29 percentage points (FY2021 to FY2025).
- In prior years, Zevra Therapeutics' Gross Margin was 68.59% in FY2024 (-23.50 pp), 92.09% in FY2023 (-5.73 pp), 97.82% in FY2022 (+5.00 pp) and 92.81% in FY2021.
- Quarterly Gross Margin has run from a low of 19.69% in Q2 2024 to a high of 99.80% in Q1 2022 over five years.
- On a year-over-year basis, Gross Margin increased in five of the last eight quarters, with an average year-over-year change of +17.36 percentage points.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q3 2025, with a gain of 57.50 percentage points; the weakest was Q2 2024, with a drop of 72.32 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 96.16% (Q2 2026), 94.76% (Q1 2026) and 95.55% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 75.71% |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 95.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 95.25% |
| Jun 30, 2026 | 96.16% |
| Mar 31, 2026 | 94.76% |
| Dec 31, 2025 | 95.55% |
| Sep 30, 2025 | 95.26% |
| Jun 30, 2025 | 52.20% |
| Mar 31, 2025 | 93.41% |
| Dec 31, 2024 | 88.63% |
| Sep 30, 2024 | 37.76% |
| Jun 30, 2024 | 19.69% |
| Mar 31, 2024 | 94.89% |
| Dec 31, 2023 | 90.50% |
| Sep 30, 2023 | 95.03% |
| Jun 30, 2023 | 92.01% |
| Mar 31, 2023 | 96.06% |
| Dec 31, 2022 | 98.91% |
| Sep 30, 2022 | 95.09% |
| Jun 30, 2022 | 96.08% |
| Mar 31, 2022 | 99.80% |
| Dec 31, 2021 | 97.71% |
API Access
Zevra Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();